ONTX : Insider Transactions for Onconova Therapeutics, Inc.

Company Profile Onconova Therapeutics is a biopharmaceutical company focused on discovering and developing small molecule product candidates primarily to treat cancer. Co. has three clinical-stage product candidates and preclinical programs. Substantially all of Co.'s effort is focused on its primary product candidate, rigosertib, which has been tested in an intravenous formulation as a single agent for patients with higher-risk myelodysplastic syndromes (MDS), and an oral formulation as a single agent in lower risk MDS or in combination with azacitidine for patients with higher-risk MDS. Co.'s other product candidate, Briciclib, is a small molecule targeting an intracellular regulatory protein, Cyclin D1.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-02-25	2023-11-24	2023-05-26	2022-05-26

Adjust Filter Settings

Records found: 181

Page 8 of 8

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

Bansal Ajay

Chief Financial OfficerOfficer

• – –

2013-07-24

$0.00

D/D

20,061

Kumar Ramesh

President and CEOOfficer

• • –

2013-07-24

$0.00

I/I

150,037

Kumar Ramesh

President and CEOOfficer

• • –

2013-07-24

$0.00

D/D

92,911

Mehta Viren

Director

– • –

2013-07-24

$0.00

D/D

11,650

Reddy E Premkumar

Director

– • –

2013-07-24

$0.00

D/D

1,187,625

Kumar Ramesh

President and CEO

• • –

2013-02-07

$15.02

$203,416

D/D

(13,543)

276,500

181 Records found	1 2 3 4 5 6 7 8	Page 8 of 8

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: